Periodontal disease is a chronic inflammatory disease resulting in destruction of the periodontal ligament and alveolar bone and can ultimately lead to tooth loss (1) . Although bacterial plaque initiates the disease process, the majority of the tissue destruction in periodontitis is associated with host, rather than bacterial, proteinases (2) . Host proteinases, such as the matrix metalloproteinases (MMPs), a family of over 20, structurally related, zinc endopeptidases, are collectively known to have the ability to degrade all components of the extracellular matrix and basement membrane. As such, the MMPs have well-described proteolytic roles in tissue destruction in a variety of disease states, including oral diseases (3, 4) .
The MMPs are numbered in terms of their order of discovery and are classified on the basis of their preferred substrates. The five major substrate-specific MMP groupings are: the collagenases (MMP-1, MMP-8 and MMP-13); the gelatinases (MMP-2 and MMP-9); the stromelysins (MMP-3, MMP-10 and MMP-11); the matrilysins (MMP-7 and MMP-26); and the membrane-type MMPs (transmembrane types: MMP-14, MMP-15, MMP-16 and MMP-24; or GPI-anchor types: MMP-17 and MMP-25) (5). Nonextracellular matrix substrates for MMPs are also emerging (6) and it is accepted that the MMPs have multifunctional roles as diverse as cytokine processing (7) and modulation of growth-factor bioavailability (8) . Basal production of MMPs is generally low, as transcription is closely and individually regulated by a variety of growth factors and cytokines (9, 10) . Furthermore, recent evidence also suggests that MMP expression is regulated post-translationally via microRNAs (11) . In addition, the enzymatic activity of MMPs is influenced by their specific localization (or compartmentalization) (12) and by the process of MMP pro-enzyme or zymogen activation (13) . The relative abundance of endogenous inhibitors, such as the TIMPs (14, 15) , and the broad-spectrum proteinase inhibitor a 2 -macroglobulin (16) , provide the final level of control of local MMP activity. Given the complexity of MMP regulation, it is important to appreciate that estimation of mRNA or protein levels of the enzymes may not correspond with MMP activity. Furthermore, because MMPs have overlapping substrate specificities, it is difficult to design substrates that are specific for a single MMP. Thus, novel assays, that combine the specificity of antibody-based approaches with the ability to measure enzyme activity using a fluorescent substrate, are required if the activity levels of individual MMPs are to be quantified successfully.
In periodontitis, neutrophils attracted to sites harbouring bacterial biofilms are a major source of MMPs, particularly MMP-8 (released from specific/ secondary granules) and MMP-9 (released from secretory/tertiary granules) (17) . MMP-8 released from neutrophils has been characterized to unwind the gross triple-helix conformation of collagen and thus initiate collagen destruction, whereas MMP-9 can only degrade collagen which has already been denatured by the collagenases (18) . The MMPs have emerged as a family of proteolytic enzymes worthy of investigation as both diagnostic aids (19) (20) (21) (22) (23) and as therapeutic targets in periodontitis (24) . Although active MMPs contribute to the ongoing tissue destruction in periodontal disease, antibody-based commercial ELISAs are commonly used to quantify MMP levels, rather than the more clinically relevant quantification of MMP activity (25) . Although more sensitive immunofluorometric assays have also been employed (23, 26, 27) , these also rely exclusively on antibodybased detection. As antibody-based methods detect all forms of MMP, including TIMP-inhibited MMP, inactive pro-MMP and active MMP, more advanced MMP assays are required for quantification of enzymatically active forms of MMPs.
MMP-8 has an important role in the initial stages of collagen degradation. It has also been shown to be highly discriminatory for the site-specific diagnosis of periodontitis (21, 23, 26) and the longitudinal monitoring of periodontitis (28) . As measuring MMP-8 abundance by ELISA does not correspond to enzyme function, the aim of this study was to develop an improved, more clinically relevant assay specifically to quantify active MMP-8 levels in gingival crevicular fluid samples.
Material and methods

Subjects
Ethical approval for the study was obtained from the Office for Research Ethics Committees Northern Ireland (ORECNI), and written consent was obtained from all participants for the collection of gingival crevicular fluid samples. Patients attending the Periodontal Clinic, School of Dentistry, Belfast, were recruited to the study. All patients were diagnosed with chronic periodontitis according to the 1999 International Workshop on the Classification of Periodontal Diseases and Conditions (29) . Patients were between 40 and 65 years of age, had a minimum of 16 teeth and at least eight teeth with sites exhibiting probing depths of ≥ 5 mm.
Collection of gingival crevicular fluid
Gingival crevicular fluid was collected as described previously (30) from a total of 15 periodontally healthy sites (from five periodontally healthy subjects) and 10 periodontally diseased sites (from nine individual patients). Briefly, teeth to be sampled were dried with warm air for 10 s and supragingival deposits of plaque were removed. A strip of PerioPaper Ò (Proflow, Amityville, NY, USA) was inserted into the gingival crevice until light resistance was felt and was then left in place for 30 s. PerioPapers contaminated with blood or saliva were rejected and an alternative site was chosen. The PerioPaper strips were placed in microtubes and stored at À80°C until required. PerioPaper strips were eluted in 250 lL of ice-cold sterile distilled water before analysis. 
MMP-8 activity assay
Cross-reactivity studies
The potential cross-reactivity of the MMP-8 activity assay against three different MMPs, namely MMP-1, MMP-2 and MMP-9 (3.125-100 ng/ mL), was studied using the method outlined above. Fluorescence measurements were recorded as described above and the activity of each of the MMPs was recorded in RFU/min, using the detection limit of the MMP-8 assay as determined above.
Statistical analysis
All statistical analyses were performed using GraphPad PRISM 4.0 software package (GraphPad, San Diego, CA, USA). The Mann-Whitney U-test was used for between-group comparisons. In all cases, p < 0.05 was taken to represent a statistically significant difference.
Results
An MMP-8 activity assay was developed, in which a specific antibody captured MMP-8 from samples before activity was measured using a FRET substrate. A schematic representation of the assay is shown in Fig. 1A . The detection limit for the MMP-8 activity assay was determined to be 8.2 RFU/ min. The MMP-8 activity of samples below the detection limit of the system were recorded as zero in subsequent analyses. A standard curve for MMP-8 activity measurements was constructed using MMP-8 standards and is shown in Fig. 1B . Cross-reactivity studies using recombinant MMP-1, MMP-2 or MMP-9 showed that these MMPs, even at concentrations up to 100 ng/mL, ranged from an average of À1.4 to +1.7 RFU/min and were all well below the detection limit of the MMP-8 activity assay (8.2 RFU/min) (Fig 1C) . By measuring the MMP-8 activity of unactivated standards before and after binding to the MMP-8 capture antibody, we showed that the assay did not cause undesirable activation of the enzyme. Thus, a sensitive and specific assay was developed for the measurement of active MMP-8.
The assay was then tested for its ability to measure active MMP-8 in both healthy and periodontally diseased gingival crevicular fluid samples. Of the 15 individual healthy sites tested, only one exhibited MMP-8 activity above the detection limit of the system ( Fig. 2A) . In contrast, of the 10 diseased sites tested, seven had MMP-8 activity levels above the detection limit of the system, ranging from 45 AE 1 to 178.9 AE 19.4 RFU/min (Fig. 2B) . The average MMP-8 activity of the healthy gingival crevicular fluid samples studied was 3.7 AE 14 RFU/min and the average MMP-8 activity of the periodontitis gingival crevicular fluid samples was significantly higher, at 78.7 AE 67.8 RFU/min (p < 0.0001) (Fig. 2C) .
Discussion
MMP-8 is acknowledged to be one of the central biomarkers in the connective tissue breakdown associated with periodontitis (4, (31) (32) (33) . Gingival crevicular fluid levels of MMP-8 have previously been shown to be significantly elevated in periodontitis (17) and MMP-8 has been proposed as a candidate diagnostic marker of periodontitis (21, 34, 35) . Based on this considerable body of evidence, the present study was designed to address the need for a novel method specifically to determine MMP-8 activity in gingival crevicular fluid (25) . Antibody-based commercial ELISAs and immunofluorometric assays are commonly used to determine MMP levels in a variety of different samples (25) (26) (27) 36) . A well-recognized limitation of these assays, however, is that they rely on MMP epitope recognition but cannot differentiate between latent and active forms, or indeed between inhibitor-bound or unbound forms of the enzyme. Therefore, the presence of MMPs in gingival crevicular fluid, as measured by ELISA-based methods, does not indicate that the enzymes are present in their active form. Indeed, ascertaining the biological and clinical significance of MMPs in periodontal disease destruction is acknowledged to be limited by difficulties in measuring specific MMP activity within a complex mixture of both host and bacterial enzymes (3) . The present study addressed and circumvented the limitations associated with ELISA methods via the development of a specific MMP-8 activity assay using a combined approach of interaction with specific antibody to capture MMP-8 from gingival crevicular fluid, followed by fluorescent substrate cleavage to measure its activity.
In validating the assay, cross-reactivity studies were undertaken to determine the potential for nonspecific detection of MMP-1, MMP-2 or MMP-9 recombinant enzymes. Given that MMP-9 has a common source from neutrophil granules and together with MMP-8 is involved in the connective tissue destruction associated with periodontal disease (7, 17, 25) , the lack of detection of MMP-9 in the novel activity assay was particularly relevant for the analysis of gingival crevicular fluid samples. This indicated that the antibody capture step was selective in removing only MMP-8 from the gingival crevicular fluid samples, thus allowing its specific quantification by the fluorescent substrate.
Roles for several MMPs in periodontal health and disease have previously been proposed (37) (38) (39) (40) (41) (42) . However, a specific role for MMP-8 in periodontitis can be traced back to studies carried out in the 1980s (43, 44) . In later years, using combinations of zymography, ELISA and colorimetric assays, gingival crevicular fluid levels of MMP-8 were shown to be significantly higher in patients with chronic periodontitis compared with healthy subjects and the levels decreased following treatment intervention (2, (45) (46) (47) . Furthermore, gingival crevicular fluid MMP-8 levels were shown to correlate with disease severity (48, 49) , strengthening the rationale for the use of a specific MMP-8 activity assay.
Conclusion
This study is the first to capture active MMP-8 from gingival crevicular fluid and subsequently determine its activity using a fluorescent substrate. We also show, for the first time, that the activity of MMP-8 was significantly increased in gingival crevicular fluid from periodontitis sites compared with healthy sites. The activity assay was shown to be sensitive and specific for MMP-8 and has the major advantage that only the enzymatically active form of MMP-8 will cleave the FRET substrate leading to its specific quantification in the assay. As it is the active form of MMP-8 that initiates collagen destruction, then the ability to measure this activity in gingival crevicular fluid should improve our understanding of the role of MMP-8 in health and disease and, in due course, facilitate biomarker development for periodontal tissue destruction.
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